Biomarkers Clinical Trial
Official title:
Biomarker Feedback on Health and Wellbeing and Exercise Adherence Following a 6 Month Weight Management Course: A Pilot Study
NCT number | NCT03809871 |
Other study ID # | LMS |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 14, 2019 |
Est. completion date | September 24, 2019 |
Verified date | September 2021 |
Source | University of Hertfordshire |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Participants who have signed up to the Watford Football Club Community and Education Trust Weight management programme called Shape Up will be approached to see if they would like to take part in this research study. Their participation in the Shape Up programme will not be affected if they do not choose to opt in to the research component. Fifty participants will be recruited and randomised in to one of two groups. One group will be the control group and they will undertake the Shape Up programme as normal and will be asked to complete some questionnaires in week 1, week 12 and then at 12 weeks follow up. The intervention group will be asked to complete the same questionnaires and will also have a venous blood sample taken at week 1, 12 and then at 12 weeks follow up. This is for measures of cholesterol, sugar, vitamin D, vitamin B12 and iron. The participants will receive a report from a medical doctor in layman terms on these results a week later and will have access to their data on an online portal set up by Medichecks. The weight management programme is based on a behaviour change programme where the participants attend a 90-minute session for 12 weeks, and they are then supported for another 12 weeks following the end of the supervision. The participants have weight and BMI measured at week 1, 12 and 12 weeks follow up. Each session consists of an education component followed by an exercise component. Initially, the education part is longer and the exercise is shorter, but as the programme progresses the education part becomes shorter and the exercise longer. The education programme includes topics such as healthy eating, increased physical activity and stress. The exercise programme includes whole body activities such as circuit training as well as other group exercise such as football. The questionnaires will include The Treatment Self-Regulation Questionnaire which will identify the motivation behind the participants' health. A general health questionnaire which is a subjective measure of health (Euro qol EQ-5). The Mental Component Summary of the 12- item Short Form (SF12) which measures emotional quality of life. Physical activity will be measured through the short Active Lives Questionnaire. All these questionnaires have been attached as appendices. All participants will complete an exit telephone interview from the study to determine qualitative feedback on their experience of the study and to explore whether the biomarkers influenced their motivation to change their lifestyle. Some example questions have been attached. This is just a feasibility study, therefore no hypothesis testing will be undertaken.
Status | Completed |
Enrollment | 43 |
Est. completion date | September 24, 2019 |
Est. primary completion date | August 30, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - BMI >28 - No injuries Exclusion Criteria: - Injury preventing from participating in exercise - fear of needles - does not pass a physical activity readiness questionnaire |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Hertforshire | Hatfield |
Lead Sponsor | Collaborator |
---|---|
University of Hertfordshire | Medichecks, Watford FC Community Sports and Education Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Behaviour regulation | To determine the behaviour regulation by measuring autonmoic regulation versus controlled regulation through the use of the Treatment Self-Regulation Questionnaire.
An average of the scores on the subscale for autoregulation and also for the controlled regulation questions will be calculated. Scores will be from 1-7 for both sub scales. |
12 months | |
Primary | Subjective health measure | A standardised measure of health status will be calculated using the Euro qol EQ-5 questionnaire. There are 5 dimensions to the questionnaire (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and each is rated from 1-5. An average of the 5 is calculated as a general health score. A visual analogue scale is also presented for a self related health measure and this is from 0-100. 100 being the best health you can imagine and 0 being the worst health you can imagine. | 12 months | |
Primary | Physical Activity | Amount of physical activity measured through the short Active Lives questionnaire. The amount of minutes where breathing is increased will be calculated per week.
For each activity that respondents indicate was sufficient to raise their breathing rate, the total number of days is multiplied by the usual minutes spent undertaking the activity to give a measure of total minutes over the 7-day period for that activity. The respondent's final score is calculated by summing all activities which were sufficient to raise breathing rate, as follows: (Days of walking * usual minutes of walking IF sufficient to raise breathing rate) + (Days of cycling * usual munities of cycling IF sufficient to raise breathing rate) + (days of sport, fitness or dance * usual minutes of sport, fitness or dance IF sufficient to raise breathing rate). |
12 months | |
Secondary | Cost savings to health care service | Extrapolating the potential cost savings to the health care service of the community programme by analysing the biomarker trend information | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Recruiting |
NCT05548933 -
Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia
|
||
Active, not recruiting |
NCT03926572 -
Acute Decompensation of Pulmonary Hypertension
|
N/A | |
Recruiting |
NCT05372159 -
Vanderbilt Memory and Aging Project
|
||
Completed |
NCT03173586 -
Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
|
N/A | |
Completed |
NCT04554628 -
Early Prediction of Acute Kidney Injury Among Patients Admitted to Surgical ICU
|
N/A | |
Terminated |
NCT03250312 -
The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers
|
N/A | |
Recruiting |
NCT04666766 -
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
|
N/A | |
Completed |
NCT04573543 -
The Role of Immune Semaphorins in NAFLD
|
||
Completed |
NCT03193671 -
Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis
|
N/A | |
Recruiting |
NCT06047132 -
PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED SUBJECTS
|
||
Completed |
NCT05361460 -
Patients Experiences of Early Postoperative Cognition
|
||
Recruiting |
NCT05706194 -
Early Neuroprognostication After OHCA
|
||
Recruiting |
NCT06446895 -
Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
|
||
Recruiting |
NCT05138731 -
Metabolomics Profiling of Coronary Heart Disease
|
||
Not yet recruiting |
NCT04563000 -
Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest
|
Phase 2 | |
Completed |
NCT05138692 -
Biomarkers and Outcome 1 and 10-15 Years After Severe Traumatic Brain Injury
|
||
Completed |
NCT02247999 -
Improving Cervical Cancer Screening Among HIV-Infected Women in India
|
||
Active, not recruiting |
NCT02732301 -
Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers
|
||
Not yet recruiting |
NCT03269019 -
Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
|
N/A |